Navigation Links
How Long Will the Economic Downturn Affect the Dental Biomaterials Market?
Date:3/24/2009

Despite minimal growth in 2009, the US dental biomaterials market will rebound to reach upwards of $230 million by 2013, according to Millennium Research Group

WALTHAM, Mass., March 24 /PRNewswire/ -- According to Millennium Research Group's (MRG's) US Markets for Dental Biomaterials 2009 report, although dental biomaterials are being used in a growing proportion of dental implant procedures, the market for these products will be dampened by the global financial crisis in the coming years as many patients postpone dental implant procedures or choose less expensive alternatives such as crowns.

Nonetheless, the US market for dental biomaterials continued to grow in 2008 due to several significant market events: BIOMET 3i's Endobon and NovaBone's NovaBone were launched in the US in the second quarter of 2008; the US import ban on Straumann's Emdogain and BoneCeramic we lifted in August, making these products available toward the end of the year; Curasan's dental business was purchased by RIEMSER Arzneimittel, a German pharmaceutical company; Regeneration Technologies and Tutogen Medical merged and now operate under the new name RTI Biologics; and Lifecore Biomedical's dental division merged with Keystone Dental following Lifecore Biomedical's acquisition by Warburg Pincus.

"These events supported market expansion in 2008 and highlight the revenue potential in the dental biomaterial space," says Kevin Flewwelling, Manager of the Orthopedics division at MRG. "Although 2009 will be a challenging year for dental biomaterial sales, market growth will continue through 2013."

MRG's US Markets for Dental Biomaterials 2009 report provides coverage of key industry competitors, including ACE Surgical Supply, BioHorizons, BIOMET 3i, DENTSPLY Friadent, Geistlich, GORE Medical Products, Keystone Dental, LifeNet Health, NovaBone Products, Osteogenics Biomedical, Ost
'/>"/>

SOURCE Millennium Research Group
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Increasing Economic and Business Risks Will Transform the Global Life Sciences Industry
2. Healthcare Executives Will Discuss How Best to Spend Economic Stimulus Money at June Conference
3. Life Science Labs Reacting to the Economic Crisis
4. Despite Economic Woes, Physician Compensation Increases
5. Patient Safety in Challenging Economic Times is Focus of NPSF Annual Congress on May 20-22
6. Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs)
7. Histogen Featured on Economic Report Television Series
8. NSD Bio Group, LLC chosen by U.S.-China Economic & Security Review Commission for Report on Chinas High Tech Sectors
9. North Carolinas Biotechnology Investment Tops Billion-Dollar Mark; Battelle Study Quantifies Economic Dividends and Jobs
10. In the Midst of International Economic Crisis, VidaCura Offers a Helping Hand to Those Without Insurance
11. OncoGenex increases economic interest in lead cancer drug OGX-011

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...d. - A new generation of ultrasmall transistors an...es called semiconducting nanowires are closer to r..., Purdue University and the University of Californ...d how to create nanowires with layers of different...level, which is a critical requirement for making ...
(Date:11/25/2009)... Nov. 25 /PRNewswire/ - Cytochroma today announced...of Directors. Dr. Moldt will replace Mr. Ulrik Spo... Board. The number of Board members remains unchan...welcome Peter Moldt to the board and look forward ...Cytochroma continues to make progress in becoming ...
(Date:11/24/2009)... Nov. 24 IES (Nasdaq: I...nd communications systems and services for the com...nced today that its commercial business group has ...o install the electrical systems for the Level 4 b...U.S. Army Medical Research Institute of Infectious...
(Date:11/24/2009)... REYKJAVIK, Iceland, November 24 /PRNewswire-F... today announced that it has received notice from,...y,s common stock will be,suspended as of November ...Securities and Exchange Commission, which will rem...unless the company files an appeal to the Nasdaq,L...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Cytochroma Announces Appointment of Peter Moldt to Board of Directors 2Integrated Electrical Services Awarded Contract to Provide Electrical Systems for U.S. Army Medical Research Institute of Infectious Diseases 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3
...EpCAM-specific Antibody Therapeutics , , BETHESD...), a biopharmaceutical company developing novel, p... inflammation and autoimmune diseases today announ...ewed journal Nature Cell Biology (1) revealing a ...dhesion molecule, or EpCAM (CD326), which is expre...
...creates growth opportunities for healthcare and li... Jan. 13 The credit crisis and the global economy...n the Healthcare industry in 2009. Healthcare in A...e developed countries. , , (Logo: http://www.new...ouis Payet, Senior Consultant of the Healthcare Pr...
....,(NasdaqGS: VARI) has announced that it will host...epth of its solutions for analytical and research,... a booth exhibitor at,Pittcon(R)2009. , Varian...ormation online.,And while the current economy may...ances to attend trade shows, individuals and insti...
Other Biology Technology:Data Published in Nature Cell Biology Reveal Novel Function of Drug Target EpCAM in Cancer Cell Signalling 2Data Published in Nature Cell Biology Reveal Novel Function of Drug Target EpCAM in Cancer Cell Signalling 3Data Published in Nature Cell Biology Reveal Novel Function of Drug Target EpCAM in Cancer Cell Signalling 42009 is Healthy for Asia 22009 is Healthy for Asia 3Varian, Inc. Announces Online Experience 2
(Date:11/24/2009)...crystallised a protein that may help gut bacteria ...uld be used by probiotic producers to identify str...le. , "Probiotics need to interact with cells lin...ey attach to surfaces in the gut they are more lik...ivity," says Dr Nathalie Juge from the Institute o...
(Date:11/24/2009)... American College of Medical Toxicology (ACMT) hav...ation of the Journal of Medical Toxicology (JMT)...arch 2010. It was previously published by the Uni...f Medical Toxicology , an international, peer-revi...e and practice of medical toxicology. The quarter...
(Date:11/24/2009)...s fish food is a matter of debate. A high-profile ...st 50 percent of their carbon from trees and leave...estrial and aquatic ecosystems. , But new resear... not likely to be true. Algae provide a much riche...to research published this week in the Proceeding...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Studying cancer in pet dogs to find new treatments for human patients 59325 1Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 1Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 2Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 3Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 4Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 5Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 6Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 7Novartis Enters Into Agreement for Exclusive US and Canadian Rights to Fanapt 28TM 29 an FDA Approved Oral Therapy for Schizophrenia 5408 8Blue Cross and Blue Shield of Georgia Foundation Donates 2425 000 to Red Cross for Flood Relief Efforts in Georgia 59322 1Blue Cross and Blue Shield of Georgia Foundation Donates 2425 000 to Red Cross for Flood Relief Efforts in Georgia 59322 2
...one of the world,s pre-eminent experts on the stud...Changes in Earth,s Polar Ice: Are We Waking Sleepi...e Gore Recital Hall of the Louise and David Rosell...Cryospheric Sciences Branch, Abdalati leads a grou...aft instruments to understand Earth,s changing ice...
...ers, in collaboration with U.S. and international ...ind of micro-switch--that can turn off genes in ri...han half the world,s population. The discovery is ...of the National Academy of Sciences of the United ... ribonucleic acids (RNAs), on the order of about 2...
... Perutz, a pioneer in the field of protein crystal...t to study the molecular structures of proteins. ..., was recently published by Cold Spring Harbor Lab...ist, wrote Dr. Richard E. Dickerson of UCLA while ... . [H]e was a fine human being with strong family...
Other Biology News:UD researchers discover novel 'gene toggles' in world's top food crop 2UD researchers discover novel 'gene toggles' in world's top food crop 3
Capillary Electrophoresis System from Agilent Technologies
P/ACE™ MDQ Molecular Characterization System from Beckman Coulter
Experion Spin Filters, 10 from Bio-Rad
55D Double Platform Shaker 12 x 16 from Reliable Scientific
Biology Products: